Investigation of hepatic adverse events due to quetiapine by using the common data model.

SooJeong KoSe-Hyun ChangYeon Woong ChungYoung-Gyun SeoDong-Yoon GangKwangsoo KimDong-Jin ChangIn Young Choi

Published in: Pharmacoepidemiology and drug safety (2023)

Our findings suggest that quetiapine should be cautiously used, and hepatic function should be monitored in patients using quetiapine because it can cause mild or severe hepatic adverse events, complications, and in rare cases, fatal liver damage. This article is protected by copyright. All rights reserved.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
risk factors
big data
patient reported outcomes
artificial intelligence